Clinical trial
Investigating the Effects of Hydroxyvitamin D3 Versus Vitamin D3 on Clinical, and Radiologic Progress and Th17/Tregs Balance in MS Patients: A Randomized, Clinical Trial- a Pilot Study
NCT05340985 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating the Effects of Hydroxyvitamin D3 Versus Vitamin D3 on Clinical, and Radiologic Progress and Th17/Tregs Balance in MS Patients: A Randomized, Clinical Trial- a Pilot Study
- Lead sponsor
- Tehran University of Medical Sciences
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2022
- Completion date
- December 31, 2023
- Enrollment
- 54 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
adult all, multiple sclerosis, relapsing-remitting, vitamin d3 deficiency